Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Teekay Group, comprising Teekay Corporation Ltd. (NYSE:TK) and its subsidiary Teekay Tankers Ltd. (NYSE:TNK), announced that it will release its second quarter 2026 financial results after market close on July 29, 2026. A conference call to discuss the results will be held on July 30, 2026, and will be available via phone and webcast.
Neutron Holdings, Inc., known as Lime, the largest global shared micromobility company, announced it will release its second quarter 2026 financial results on August 4, 2026, followed by a conference call. Lime offers e-bikes and e-scooters as sustainable transportation solutions worldwide and has facilitated over one billion rides.
Rocky Mountain Chocolate Factory, Inc. reported its financial results for the first quarter of fiscal 2027 ending May 31, 2026, highlighting a net loss of $1.2 million compared to a loss of $0.3 million the previous year. Total revenue slightly declined to $6.1 million from $6.4 million, with increases in product and retail sales offset by decrease…
Suja Life, a leading organic and better-for-you beverage company, announced it will report its second quarter 2026 financial results on August 4, 2026, followed by a conference call and webcast. The company highlights its strong position in the natural healthy beverage market with its brand portfolio including Suja Organic, Vive Organic, and Slice …
Kestra Medical Technologies, a Nasdaq-listed wearable medical device and digital healthcare company, announced a $200 million non-dilutive term loan financing agreement with Pharmakon Advisors. The facility offers flexible tranches to fund growth initiatives and acquisitions, with interest-only payments for 48 months, enhancing Kestra’s financial f…
AVITA Medical, a therapeutic acute wound care company, announced that it will report its second quarter 2026 financial results on August 6, 2026, after U.S. market close. The company will hold a conference call and webcast to discuss results and business highlights. The company specializes in wound healing technologies including RECELL, an FDA-appr…
Rapid7, Inc., a NASDAQ-listed AI-powered managed cybersecurity operations company, announced it will report its Q2 2026 financial results on August 10, 2026, followed by a conference call to discuss the results and outlook. The company provides cybersecurity services to over 11,500 customers globally, focusing on AI-driven threat detection and risk…
Apollo-managed funds have completed the acquisitions of Emerald Holding, Inc. and Questex, LLC, combining two major B2B event organizers into a scaled, experiential events and media platform. The integration aims to accelerate organic growth, expand capabilities, and enhance value for stakeholders. Leadership appointments have been announced to ste…
Annexon, Inc. announced an upcoming oral presentation at ASRS 2026 highlighting baseline characteristics linked to vision loss in geographic atrophy patients from the Phase 2 ARCHER trial of vonaprument, its novel neuroprotective therapy. The Phase 2 results demonstrated significant preservation of vision in dry age-related macular degeneration pat…
Semtech Corp. President and CEO Hou Hong Q executed a sale of 2,000 shares on July 10, 2026, totaling $266,000 under a pre-established Rule 10b5-1 plan adopted in late 2025. The transaction leaves Dr. Hou with 64,799 shares in the company. While the stock has appreciated significantly over the past year, reaching $141.46, valuation metrics present …
Vivani Medical, a NASDAQ-listed biopharmaceutical company, announced its scheduled presentation at the Emerging Growth Conference on July 15, 2026. The company focuses on developing novel GLP-1 drug implants designed for once- or twice-yearly administration to improve medication adherence for metabolic diseases such as obesity and type 2 diabetes. …
Xencor is a small-cap biotech ($1.11B market cap) that has been transitioning from partner-driven royalties to an increasingly in-house clinical portfolio built on its XmAb platform. With revenue momentum (Q2 2025 revenue up 82% to $43.6M), a recent financing haul and visible milestone receipts, the stock at $14.95 looks like a reasonable long trad…
Astec Industries, a manufacturer of specialized equipment for asphalt road building and aggregate processing, announced its upcoming second quarter 2026 earnings release and conference call scheduled for August 5, 2026. The call will provide details on the company's financial performance and business outlook, hosted by senior management.
Monolithic Power Systems, a fabless semiconductor company, will report its second quarter 2026 financial results on July 30, 2026, after market close. The company plans to hold a webinar the same day to discuss results and outlook.
Kestra Medical Technologies announced strong financial results for Q4 and fiscal year 2026, with significant revenue growth driven by increased market share and wearable cardioverter defibrillator market expansion. The company expanded gross margins substantially and outlined a robust FY27 revenue forecast of $137 million, indicating confidence in …
Ascent Solar Technologies, Inc. highlighted significant commercial progress in the first half of 2026, including expanded customer base, successful space-grade testing, development of power beaming technology, and a $25 million private placement. The company plans to accelerate growth in diverse sectors such as space, marine, and high-altitude plat…
Sezzle Inc., a fintech company specializing in point-of-sale digital payment solutions, will release its earnings for the second quarter of 2026 on August 6. The company will host a conference call and webcast to discuss results and will participate in multiple investor conferences in August and September focused on fintech and consumer finance. Th…
Crescent Biopharma announced an underwritten public offering of ordinary shares and pre-funded warrants, including a 30-day option for underwriters to buy additional shares. The offering aims to raise capital to advance its clinical-stage oncology pipeline, including a PD-1 x VEGF bispecific antibody and antibody-drug conjugates. The offering is su…
Wabash National Corporation (NYSE: WNC) disclosed the commencement of a private offering of $100 million in convertible senior unsecured notes due 2032, with an option for an additional $15 million. The offering aims to raise funds for general corporate purposes, including repaying existing debt. The notes provide conversion rights and redemption o…
MKS Inc., a NASDAQ-listed global technology company, has been named one of the 2026-2027 Best Companies to Work For by U.S. News & World Report, marking its fourth consecutive year on the list. The recognition reflects MKS's strong employee satisfaction, workplace culture, and commitment to offering rewarding career opportunities across its operati…
Stifel has revised its near-term preference within the optical components sector, moving from Coherent to Lumentum. The change reflects narrowing valuation gaps among major suppliers and a renewed emphasis on revenue growth potential and medium-term margin prospects. Stifel highlights a supply shortage in external modulator lasers and notes recent …
The U.S. Food and Drug Administration approved gedatolisib, marketed as Revtorpyk, for a defined group of advanced breast cancer patients. The approval, based on late-stage trial data, covers use of Revtorpyk in combination with Pfizer's Ibrance and fulvestrant and follows evidence of a substantial reduction in the risk of disease progression or de…
Celcuity's stock jumped 6.6% in afternoon trading as market participants positioned ahead of an imminent FDA decision on gedatolisib, the company's lead oncology candidate. The drug's New Drug Application was accepted under the FDA's Real-Time Oncology Review program and granted Priority Review; gedatolisib also holds Breakthrough Therapy and Fast …
Argentina's consumer prices rose 1.9% in June, the national statistics agency INDEC reported, continuing a three-month trend of decelerating monthly inflation. The 12-month inflation rate climbed to 33.5% through June, slightly below analyst forecasts, while some categories such as recreation and housing saw larger price gains and communications an…
A top House Judiciary Democrat has written to Paramount's CEO seeking answers about whether the company or its leadership has been steering CBS News to broadcast material favorable to President Donald Trump. The letter raises concerns about editorial independence after personnel changes at CBS News and prior actions tied to mergers and settlements …
